흡입 스테로이드제제의 Update

키워드

참고문헌 (26)

1. National asthma education and prevention program: global strategy for asthma management and prevention. Global initiative for asthma report, "National Institutes of Health, National Heart, Lung, and Blood Institute", ~ (2009)
2. "High-resolution CT findings in patients with near-fatal asthma - Comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment", CHEST, 126, pp.1840~1848
3. Chetta A, "Airways remodeling is a distinctive feature of asthma and is related to severity of disease", Chest, 111, pp.852~857 (1997)
4. Reed CE, "The natural history of asthma in adults: the problem of irreversibility", J Allergy Clin Immunol, 103, pp.539~547 (1999)
5. Ten Hacken NH, "Airway remodeling and long-term decline in lung function in asthma", Curr Opin Pulm Med, 9, pp.9~14 (2003)
6. Barnes PJ, "Efficacy of inhaled corticosteroids in asthma", J Allergy Clin Immunol, 102, pp.531~553 (1998)
7. "2007 한국 성인천식의 치료지침" (2007)[URL]
8. Barnes PJ, "Corticosteroids: the drugs to beat", Eur J Pharmacol, 533, pp.2~14 (2006)
9. Kelly HW, "Comparison of inhaled corticosteroids: an update", Ann Pharmacother, 43, pp.519~527 (2009)
10. Deeks ED, "Ciclesonide: a review of its use in the management of asthma", Drugs, 68, pp.1741~1770 (2008)
11. Derom E, "Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5’onophosphate in asthmatic patients", Pulm Pharmacol Ther, 18, pp.328~336 (2005)
12. Lee DK, "Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma", Chest, 127, pp.851~860 (2005)
13. Pedersen S, "A comparative study of inhaled ciclesonide 160 microg", day and fluticasone propionate 176 microg, Pediatr Pulmonol, pp.2006, 41[DOI]
14. O’onnor B, "Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator", Ann Allergy Asthma Immunol, 86, pp.397~404 (2001)
15. Sharpe M, "Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma", Drugs, 61, pp.1325~1350 (2001)
16. Kelly HW, "Comparison of inhaled corticosteroids", Ann Pharmacother, 32, pp.220~232 (1998)
17. Winkler J, "How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids", Proc Am Thorac Soc, 1, pp.356~363 (2004)
18. Kelly HW, "Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids", Ann Allergy Asthma Immunol, 91, pp.326~334 (2003)
19. Hübner M, "Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids", Immunol Allergy Clin North Am, 25, pp.469~488 (2005)
20. Rossi GA, "Safety of inhaled corticosteroids: room for improvement", Pulm Pharmacol Ther, 20, pp.23~35 (2007)
21. Derendorf H, "Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma", Eur Respir J, 28, pp.1042~1050 (2006)
22. Fanta CH, "Asthma", N Engl J Med, 360, pp.1002~1014 (2009)
23. Rodrigo GJ, "Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation", Chest, 130, pp.1301~1311 (2006)
24. Busse WW, "Pathophysiology of severe asthma", J Allergy Clin Immunol, 106, pp.1033~1042 (2000)
25. Jang AS, "Risk factors related to fixed airway obstruction in patients with asthma after antiasthma treatment", ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 99, pp.408~412 (2007), AMER COLL ALLERGY ASTHMA IMMUNOLOGY
26. Adcock IM, "New targets for drug development in asthma", Lancet, 372, pp.1073~1087 (2008)

관련 논문AI추천